MALLORY LLOYD: Open Payments
NPI 1023636776 · COUNCIL BLUFFS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 48 payments from 13 companies in 2025. Trend: 2023 $305 · 2024 $545 · 2025 $731
Food & beverage: $686Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $234 |
| ABBVIE INC. | 12 | $163 |
| Novo Nordisk Inc | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| PFIZER INC. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Astellas Pharma US Inc | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
Products named: VRAYLAR, JARDIANCE, MOUNJARO, CAPLYTA, QULIPTA, Wegovy, Veozah, SPRAVATO.
Industry payments across IA — which companies pay providers there.
